Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126097531 | 12609753 | 1 | I | 20120220 | 20160707 | 20160801 | 20160801 | EXP | IT-CIPLA LTD.-2016IT09606 | CIPLA | 0.00 | Y | 0.00000 | 20160801 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126097531 | 12609753 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | 400 MG CYCLICAL | Y | U | 0 | 400 | MG | INJECTION | |||||
| 126097531 | 12609753 | 2 | SS | Epirubicin | EPIRUBICIN | 1 | Intravenous (not otherwise specified) | 90 MG, CYCLICAL | Y | 0 | 90 | MG | |||||||
| 126097531 | 12609753 | 3 | C | DECADRON | DEXAMETHASONE | 1 | 20 MG | U | U | 0 | |||||||||
| 126097531 | 12609753 | 4 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | 8 MG | U | U | 0 | 8 | MG | |||||||
| 126097531 | 12609753 | 5 | C | Sinvacor | SIMVASTATIN | 1 | Oral | 1 DF | U | U | 0 | 1 | DF | TABLET | |||||
| 126097531 | 12609753 | 6 | C | Minias | LORMETAZEPAM | 1 | Oral | 20 GTT | U | U | 0 | ||||||||
| 126097531 | 12609753 | 7 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 20 MG, UNK | U | U | 0 | 20 | MG | TABLET | |||||
| 126097531 | 12609753 | 8 | C | Mepral | OMEPRAZOLE SODIUM | 1 | Oral | 20 MG, UNK | U | U | 0 | 20 | MG | ||||||
| 126097531 | 12609753 | 9 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 13.8 G, UNK | U | U | 0 | 13.8 | G | ||||||
| 126097531 | 12609753 | 10 | C | Gliclazide | GLICLAZIDE | 1 | Unknown | 60 MG, UNK | U | U | 0 | 60 | MG | ||||||
| 126097531 | 12609753 | 11 | C | Tesavel | SITAGLIPTIN PHOSPHATE | 1 | Oral | 100 MG, UNK | U | U | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126097531 | 12609753 | 1 | Endometrial cancer |
| 126097531 | 12609753 | 2 | Endometrial cancer |
| 126097531 | 12609753 | 3 | Inflammation |
| 126097531 | 12609753 | 4 | Prophylaxis of nausea and vomiting |
| 126097531 | 12609753 | 5 | Product used for unknown indication |
| 126097531 | 12609753 | 6 | Product used for unknown indication |
| 126097531 | 12609753 | 7 | Product used for unknown indication |
| 126097531 | 12609753 | 8 | Product used for unknown indication |
| 126097531 | 12609753 | 9 | Product used for unknown indication |
| 126097531 | 12609753 | 10 | Product used for unknown indication |
| 126097531 | 12609753 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126097531 | 12609753 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126097531 | 12609753 | Flank pain | |
| 126097531 | 12609753 | Neutropenia | |
| 126097531 | 12609753 | Tongue ulceration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126097531 | 12609753 | 1 | 20111122 | 20120220 | 0 | |
| 126097531 | 12609753 | 2 | 20111122 | 20120220 | 0 | |
| 126097531 | 12609753 | 3 | 20111122 | 20120220 | 0 | |
| 126097531 | 12609753 | 4 | 20111122 | 20120220 | 0 |